Antibacterial Nanostructured Surfaces Modulate Protein Adsorption, Inflammatory Responses, and Fibrous Capsule Formation
- 23 November 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (1) , 220-235
Abstract
The present study interrogates the interaction of highly efficient antibacterial surfaces containing sharp nanostructures with blood proteins and the subsequent immunological consequences, processes that are of key importance for the fate of every implantable biomaterial. Studies with human serum and plasma pointed to significant differences in the composition of the protein corona that formed on control and nanostructured surfaces. Quantitative analysis using liquid chromatography-mass spectrometry demonstrated that the nanostructured surface attracted more vitronectin and less complement proteins compared to the untreated control. In turn, the protein corona composition modulated the adhesion and cytokine expression by immune cells. Monocytes produced lower amounts of pro-inflammatory cytokines and expressed more anti-inflammatory factors on the nanostructured surface. Studies using an in vivo subcutaneous mouse model showed reduced fibrous capsule thickness which could be a consequence of the attenuated inflammatory response. The results from this work suggest that antibacterial surface modification with sharp spike-like nanostructures may not only lead to the reduction of inflammation but also more favorable foreign body response and enhanced healing, processes that are beneficial for most medical devices implanted in patients.Keywords
Funding Information
- University of South Australia
- National Health and Medical Research Council (GNT1194466)
- Australian Research Council (DP180101254, DP220103543)
- Innovative Manufacturing CRC (IMCRC/GOT/13032018)
- Alexander von Humboldt-Stiftung
- Corin Australia Pty Ltd
This publication has 60 references indexed in Scilit:
- Periprosthetic joint infection: Current conceptIndian Journal of Orthopaedics, 2013
- Immune responses to implants – A review of the implications for the design of immunomodulatory biomaterialsBiomaterials, 2011
- Apolipoprotein E inhibits Toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanismsBiochemical Journal, 2010
- The plasminogen activation system in inflammationFrontiers in Bioscience-Landmark, 2008
- Vitronectin is a critical protein adhesion substrate for IL‐4‐induced foreign body giant cell formationJournal of Biomedical Materials Research Part A, 2007
- Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humansJournal of Translational Medicine, 2007
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Journal of Bone and Joint Surgery, 2007
- The effect of the surface modification of titanium using a recombinant fragment of fibronectin and vitronectin on cell behaviorBiomaterials, 2005
- Mechanism of initial attachment of cells derived from human bone to commonly used prosthetic materials during cell cultureBiomaterials, 1994
- Vitronectin and its receptorsCurrent Opinion in Cell Biology, 1993